Explore our news page for thought leadership articles, technical expertise and the latest developments in the world of innovation funding.
Filter
The specialist R&D tax credit team at Myriad has once again been successful in its Client’s appeal to the First-Tier Tax Tribunal. Read our latest article to learn more.
Myriad is excited to announce an essential win for the software development industry, in our recent battle with HMRC over an R&D tax credit claim dispute.
Dive into the excitement of the Welford Victoria FC U8s local derby, sponsored by Myriad.
The Myriad Associates grant team have done it again. They’ve won over £200,000 worth of funding from UK Research and Innovation (UKRI) as part of their UK-Canada competition.
The Grants team at Myriad Associates are proud to announce that they have secured over €30m from the Disruptive Technologies Innovation Fund (DTIF).
Onkimmune was founded in 2015 with the goal of developing novel anti-cancer therapies using Natural Killer (NK) cells.
Myriad Associates is proud to announce that 4 of our clients who applied for the Disruptive Technologies Innovation Fund were all approved on Monday 10th December.